Breaking news from Day 3 of ESCRS
Breakthrough micro-lens treatment for presbyopia
The Flexivue System, a breakthrough implantable micro-lens treatment for presbyopia from Presbia Coöperatief was unveiled at the show and it is keenly anticipated that it will be in clinical trials in several European countries by the end of the year.
Alcon to acquire Swiss Biotechnology business
The news broke at today's show that Alcon is to gain access to proprietary antibody fragment technology particularly suited to treat eye diseases with its plan to acquire ESBATech AG, a Swiss biotechnology firm.
Toric IOL enhances refractive outcomes
Rayner, the world's first IOL manufacturer, unveiled a dynamic new brand identity at ESCRS and held a seminar today to highlight the success doctors are having with its range of toric IOLs. Headlined A Roadmap to Success the seminar featured presentations from seven European doctors relating their experiences of using Rayner's toric IOLs.
More news from the congressImproving retinal examination speed and efficiency Megatron S4 from Geuder delivers flexibility and mobilityThree steps to better toric surgeryA quartet of solutions for surgeonsAt the sharp endAn all in one optical biometer